Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Retrovirology

Fig. 1

From: Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients

Fig. 1

Western blots (Genelabs HTLV 2.4) of antibodies to natural and recombinant HTLV-1 antibodies. To assist with interpretation, only relevant HTLV-1/2 antigens have been highlighted. GD21 is a recombinant p21 transmembrane envelope protein; rgp46-1 and rgp46-2 are recombinant gp46 surface proteins specific for HTLV-1 and HTLV-2, respectively. p19 and p24 are group antigens (gag) from the nucleus. HTLV-1 positive control shown in lanes 1 and 4, HTLV-2 positive control in lane 2, negative control in lane 3. Case 1 (lanes 513) days 16, 32, 46, 71, 74, 186, 214, 242 and 270 post transplantation, shown in sequence. Case 2 (lanes 1418) days 16, 39, 95, 136 and 254 post transplantation, shown in sequence. Case 3 (lanes 1925) days.16, 23, 30, 37, 75, 145 and 208 post transplantation, shown in sequence

Back to article page